{"id":1557,"date":"2026-06-01T21:57:06","date_gmt":"2026-06-02T01:57:06","guid":{"rendered":"https:\/\/www.insilens.com\/?p=1557"},"modified":"2026-06-01T21:58:44","modified_gmt":"2026-06-02T01:58:44","slug":"kelonia-therapeutics-in-vivo-car-t-clinical-update","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=1557","title":{"rendered":"Kelonia Therapeutics \u2013 In Vivo CAR-T Clinical Update"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1557\" class=\"elementor elementor-1557\">\n\t\t\t\t<div class=\"elementor-element elementor-element-56a770e e-flex e-con-boxed e-con e-parent\" data-id=\"56a770e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-eb0f875 elementor-widget elementor-widget-image\" data-id=\"eb0f875\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"512\" src=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-1-2026-09_56_14-PM-768x512.png\" class=\"attachment-medium_large size-medium_large wp-image-1558\" alt=\"\" srcset=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-1-2026-09_56_14-PM-768x512.png 768w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-1-2026-09_56_14-PM-300x200.png 300w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-1-2026-09_56_14-PM-1024x683.png 1024w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-1-2026-09_56_14-PM.png 1536w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1e302a2 e-flex e-con-boxed e-con e-parent\" data-id=\"1e302a2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-39d80ef3 elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"39d80ef3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Summary<\/h4><p>Kelonia Therapeutics presented updated ASCO 2026 data supporting continued advancement of its in vivo CAR-T platform, which engineers CAR-T cells directly inside patients using targeted lentiviral delivery technology.<\/p><h4>What Happened<\/h4><p>Kelonia shared updated clinical progress from its in vivo CAR-T platform at ASCO 2026. Rather than harvesting T cells and manufacturing CAR-T products externally, the company aims to generate CAR-T cells directly inside the patient.<\/p><h4>Deep Analysis<\/h4><p>In vivo CAR-T is one of the most important long-term objectives in cell therapy. If successful, it could eliminate manufacturing cost, vein-to-vein delays, scalability constraints, and access limitations. The platform has the potential to transform CAR-T from a manufacturing service into a drug-like therapeutic modality.<\/p><h4>Company \/ Product Background<\/h4><p>Kelonia Therapeutics is developing targeted lentiviral delivery technologies designed to engineer immune cells directly inside the body.<\/p><h4>Signal Extraction<\/h4><p>&#8211; In vivo CAR-T remains a major platform opportunity<br \/>&#8211; Potential elimination of manufacturing bottlenecks<br \/>&#8211; Direct challenge to autologous CAR-T models<br \/>&#8211; Broad future applicability across oncology and immune diseases<\/p><h4>Insilens Take<\/h4><p>&#8211; Opportunity: Scalable cell therapy architecture<br \/>&#8211; Risk: Delivery specificity and safety<br \/>&#8211; Watch Signal: Durable responses and expansion cohorts<br \/>&#8211; Action: Monitor competitive positioning versus ex vivo CAR-T<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Summary Kelonia Therapeutics presented updated ASCO 2026 data supporting continued advancement of its in vivo CAR-T platform, which engineers CAR-T cells directly inside patients using targeted lentiviral delivery technology. What Happened Kelonia shared updated clinical progress from its in vivo CAR-T platform at ASCO 2026. Rather than harvesting T cells and manufacturing CAR-T products externally, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1558,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,3],"tags":[],"class_list":["post-1557","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-categories","category-therapeutic-indication"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1557"}],"version-history":[{"count":4,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1557\/revisions"}],"predecessor-version":[{"id":1562,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1557\/revisions\/1562"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/1558"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}